Stem cells

Facebook Twitter

The False Controversy of Stem Cells. Congratulations to representative Dana Rohrabacher, 56, and his wife Rhonda, 34, who gave birth to triplets last month.

The False Controversy of Stem Cells

As we tend to suspect when a couple has triplets, the new parents used the services of a fertility clinic. Modern in-vitro techniques generally involve creating multiple embryos in the laboratory, transferring two or three and hoping that at least one will make it through to birth. Often it doesn't work. Sometimes it works unexpectedly well. Successful or not, the process creates many more embryos than babies. StemCellControversy_Article.pdf (application/pdf Object) Ethical concerns about embryos in fertility clinics. Handling surplus embryos in fertility clinics Sponsored link.

Ethical concerns about embryos in fertility clinics

In order to understand why the surplus embryos represent a serious concern to some people, it is necessary to study the basics of human personhood, the activities of the pro-life community, and procedures performed in fertility clinics: When does personhood begin? No consensus exists about when human life becomes a human person.

Human life can be defined as any living entity that contains human DNA. Many pro-lifers look at the inventory of frozen embryos in a fertility clinic as a potential adoption facility. Sponsored link: Human stem cell research: all viewpoints. Morality; controversial topics Menu Sponsored link.

Human stem cell research: all viewpoints

McLaren-EthicalAndSocialDimensions-Nature.pdf (application/pdf Object) Oct‐4‐expressing cells in human amniotic fluid: a new source for stem cell research? + Author Affiliations 1To whom correspondence should be addressed. e‐mail: markus.hengstschlaeger@akh‐wien.ac.at Received October 2, 2002.

Oct‐4‐expressing cells in human amniotic fluid: a new source for stem cell research?

Revision received February 13, 2003. Accepted March 18, 2003. Seeking superior stem cells. 10 October 2011.

Seeking superior stem cells

Drug May Dampen Dangerous Side Effect of Stem Cell Transplants. The United Nations report into the 14-month uprising against President Bashar al-Assad said government forces routinely drew up lists of wanted people and their families before blockading then attacking a village or neighborhood.

Drug May Dampen Dangerous Side Effect of Stem Cell Transplants

"Entire families were executed in their homes - usually the family members of those opposing the government such as the family members of Colonel Riad al-Asaad," it said, referring to relatives of the head of the rebel Free Syrian Army. The rebels, who are increasingly armed and well-organized, have executed or tortured soldiers and government supporters, said the U.N., whose investigators were not allowed into Syria and relied on interviews of victims and witnesses. Violence has raged despite a U.N. -brokered agreement on April 12 aimed at halting the bloodshed in Syria, where Assad is confronting an uprising which began with peaceful protests but has become increasingly militarized.

Opposition activists reported fighting in several regions on Thursday. Scalable amounts of liver and pancreas precursor cells created using new stem cell production method. Scientists in Canada have overcome a key research hurdle to developing regenerative treatments for diabetes and liver disease with a technique to produce medically useful amounts of endoderm cells from human pluripotent stem cells.

Scalable amounts of liver and pancreas precursor cells created using new stem cell production method

The research, published in Biotechnology and Bioengineering, can be transferred to other areas of stem cell research helping scientists to navigate the route to clinical use known as the 'valley of death'. "One million people suffer from type 1 diabetes in the United States, while liver disease accounts for 45,000 deaths a year," said Dr Mark Ungrin from the University of Toronto. "This makes stem cells, and the potential for regenerative treatments, hugely interesting to scientists. Laboratory techniques can produce thousands, or even millions, of these cells, but generating them in the numbers and quality needed for medicine has long been a challenge. " Why Would the Leader in Embryonic Stem Cell Research Drop Out? Translating Theory Into Treatments More Difficult Than Expected | 3593 hits WASHINGTON, D.C., NOV. 30, 2011 (Zenit.org).- Here is a question on bioethics asked by a ZENIT reader and answered by the fellows of the Culture of Life Foundation.

Why Would the Leader in Embryonic Stem Cell Research Drop Out?

Q: Now that Geron has discontinued its embryonic stem cell research, while at the same time adult stem cell experiments have had a number of successful trials, what does this mean for the stem cell debate? - FJF, Australia. E. GERON GIVES UP on EMBRYONIC STEM CELLS! « The Stem Cell Blog. Ageing stem cells from centenarian rejuvenated. Scientists Create Brain Cells From Skin Cells - Stanford breakthrough in mice skips stem cell stage.

(User Submitted) – In what's being heralded as "a huge leap forward," Stanford researchers have successfully turned mouse skin cells into fully functioning brain cells.

Scientists Create Brain Cells From Skin Cells - Stanford breakthrough in mice skips stem cell stage

The process, which took less than a week, upends thinking on how cells develop specialized roles, and could help minimize the controversial role of embryonic stem cells in treatments for diseases like Parkinson's and Alzheimer's. "These are fully functional neurons," researcher Marius Wernig told AFP. Operation marks another step forward in stem cell research. Dr.

Operation marks another step forward in stem cell research

Nicholas Boulis adjusts the device that injects stem cells into the cervical area of the spinal cord. For the first time, stem cells are injected into the spinal cord in the neckIt is part of a trial to see if the procedure can be safely done "I feel like we finally arrived," says the surgeon who invented a key structure Atlanta (CNN) -- A 50-year-old man from Trion, Georgia, is the first person to be injected with stem cells in the upper part of the spinal cord, making him yet another pioneer in the scientific quest to use stem cells to heal. Richard Grosjean received the treatment Friday. He is part of an ongoing FDA-approved clinical trial that is testing the safety of injecting stem cells into the spinal cords of patients with amyotrophic lateral sclerosis, or ALS, also known as Lou Gehrig's disease.